Yuchen Hu, Junchao Zhou, Yuhang Gao, Ban Chen, Jiangtao Su, Hong Li
{"title":"Deep Learning Accelerates the Development of Antimicrobial Peptides Comprising 15 Amino Acids.","authors":"Yuchen Hu, Junchao Zhou, Yuhang Gao, Ban Chen, Jiangtao Su, Hong Li","doi":"10.1089/adt.2025.011","DOIUrl":null,"url":null,"abstract":"<p><p>\n <i>The emergence of multidrug-resistant bacteria has led to an urgent need for novel antimicrobial agents. Antimicrobial peptides (AMPs) exhibit broad-spectrum and highly effective antibacterial activity and are less prone to resistance, making them potential candidates for the next generation of antimicrobial drugs. However, screening for AMPs from a vast library of peptides through wet lab experiments is a slow and laborious process. By leveraging large datasets of labeled peptides, researchers utilize deep learning algorithms to train models that capture complex patterns and features associated with antimicrobial activity, which advance the discovery and development of novel AMPs. Since the discovery of certain lengths of AMPs has been rarely reported, we applied deep learning to accelerate the discovery of AMPs consisting of 15 amino acids and developed a model named AMPPRED15 in this article. Wet lab experiments were also conducted to evaluate the performance of the model. Fortunately, we successfully identified two AMPs, one of which demonstrated antibacterial activities comparable to the marketed antibiotic cefoperazone sodium.</i>\n </p>","PeriodicalId":8586,"journal":{"name":"Assay and drug development technologies","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Assay and drug development technologies","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/adt.2025.011","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
The emergence of multidrug-resistant bacteria has led to an urgent need for novel antimicrobial agents. Antimicrobial peptides (AMPs) exhibit broad-spectrum and highly effective antibacterial activity and are less prone to resistance, making them potential candidates for the next generation of antimicrobial drugs. However, screening for AMPs from a vast library of peptides through wet lab experiments is a slow and laborious process. By leveraging large datasets of labeled peptides, researchers utilize deep learning algorithms to train models that capture complex patterns and features associated with antimicrobial activity, which advance the discovery and development of novel AMPs. Since the discovery of certain lengths of AMPs has been rarely reported, we applied deep learning to accelerate the discovery of AMPs consisting of 15 amino acids and developed a model named AMPPRED15 in this article. Wet lab experiments were also conducted to evaluate the performance of the model. Fortunately, we successfully identified two AMPs, one of which demonstrated antibacterial activities comparable to the marketed antibiotic cefoperazone sodium.
期刊介绍:
ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application.
ASSAY and Drug Development Technologies coverage includes:
-Assay design, target development, and high-throughput technologies-
Hit to Lead optimization and medicinal chemistry through preclinical candidate selection-
Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis-
Approaches to assays configured for gene families, inherited, and infectious diseases-
Assays and strategies for adapting model organisms to drug discovery-
The use of stem cells as models of disease-
Translation of phenotypic outputs to target identification-
Exploration and mechanistic studies of the technical basis for assay and screening artifacts